{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:54:04Z","timestamp":1785876844889,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2024\/11363-1"],"award-info":[{"award-number":["2024\/11363-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2024\/02302-9"],"award-info":[{"award-number":["2024\/02302-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2023\/17292-6"],"award-info":[{"award-number":["2023\/17292-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009568","name":"UNESP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009568","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["307280\/2022-5"],"award-info":[{"award-number":["307280\/2022-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["307703\/2022-3"],"award-info":[{"award-number":["307703\/2022-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["140400\/2019-2"],"award-info":[{"award-number":["140400\/2019-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119719","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T10:57:29Z","timestamp":1782557849000},"page":"119719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effects of SGLT2 inhibitor dapagliflozin on the heart of rats with long-standing Type 1 diabetes mellitus: Protein profile"],"prefix":"10.1016","volume":"201","author":[{"given":"Eder Anderson","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Dionizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Moreno","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dijon Henrique Salom\u00e9","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Cesar","family":"Damatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Raphael Abreu","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidiane Moreira","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila Portugal","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Aparecida","family":"Borim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana Urbano","family":"Pagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara Teodoro","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilia Afonso Rabelo","family":"Buzalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thulio Marques","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katashi","family":"Okoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Politi","family":"Okoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119719_bib1","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1161\/CIR.0000000000001412","article-title":"2026 Heart Disease and Stroke Statistics: a report of US and global data from the American Heart Association","volume":"153","author":"Palaniappan","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2026.119719_bib2","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2026.119719_bib3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10741-021-10200-y","article-title":"Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants","volume":"28","author":"Prandi","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.biopha.2026.119719_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12933-015-0255-7","article-title":"Rutin administration attenuates myocardial dysfunction in diabetic rats","volume":"14","author":"Guimaraes","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2026.119719_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2026.119719_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1112858","article-title":"The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetes","volume":"14","author":"Roep","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119719_bib7","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMra2115011","article-title":"Gliflozins in the management of cardiovascular disease","volume":"386","author":"Braunwald","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119719_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41581-024-00836-y","article-title":"Applications of SGLT2 inhibitors beyond glycaemic control","volume":"20","author":"O\u2019Hara","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2026.119719_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2026.178647","article-title":"Redefining SGLT2 inhibitors through cytoprotective mechanisms","volume":"1016","author":"Stankovic","year":"2026","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119719_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41569-020-0406-8","article-title":"SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control","volume":"17","author":"Cowie","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2026.119719_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41569-022-00824-4","article-title":"SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism","volume":"20","author":"Packer","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2026.119719_bib12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCULATIONAHA.123.064346","article-title":"Critical analysis of the effects of SGLT2 inhibitors on renal tubular sodium, water and chloride homeostasis and their role in influencing heart failure outcomes","volume":"148","author":"Packer","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2026.119719_bib13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/antiox14060647","article-title":"Impact of SGLT2i on cardiac remodeling and the soleus muscle of infarcted rats","volume":"14","author":"Souza","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2026.119719_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101501","article-title":"Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: the Dapa-ON multicenter retrospective study","volume":"50","author":"Dur\u00e1n-Mart\u00ednez","year":"2024","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.biopha.2026.119719_bib15","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3390\/ijms25041972","article-title":"Risks and Benefits of SGLT-2 inhibitors for type 1 diabetes patients using automated insulin delivery systems\u2014a literature review","volume":"25","author":"Elian","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119719_bib16","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/clinem\/dgac618","article-title":"Clinical and safety outcomes with GLP-1 receptor agonists and SGLT2 inhibitors in type 1 diabetes: A real-world study","volume":"108","author":"Edwards","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2026.119719_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11892-022-01471-2","article-title":"SGLT2 Inhibition in type 1 diabetes with diabetic kidney disease: potential cardiorenal benefits can outweigh preventable risk of diabetic ketoacidosis","volume":"22","author":"Liu","year":"2022","journal-title":"Curr. Diab Rep."},{"key":"10.1016\/j.biopha.2026.119719_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/dom.14556","article-title":"Off-label use of sodium glucose co-transporter inhibitors among adults in type 1 diabetes exchange registry","volume":"24","author":"Hughes","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.biopha.2026.119719_bib19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00592-021-01686-x","article-title":"Sodium\u2013glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: Meta-analysis of randomized controlled trials","volume":"58","author":"Rao","year":"2021","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.biopha.2026.119719_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13098-023-01196-6","article-title":"The influence of dapagliflozin on cardiac remodeling, myocardial function and metabolomics in type 1 diabetes mellitus rats","volume":"15","author":"Rodrigues","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.biopha.2026.119719_bib21","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3390\/antiox11050982","article-title":"Effects of the SGLT2 inhibition on cardiac remodeling in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus","volume":"11","author":"Rosa","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2026.119719_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.999254","article-title":"Multi-omics insights into potential mechanism of SGLT2 inhibitors cardiovascular benefit in diabetic cardiomyopathy","volume":"9","author":"Xi","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2026.119719_bib23","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/cvr\/cvad009","article-title":"Empagliflozin inhibits excessive autophagy through the AMPK\/GSK3\u03b2 signalling pathway in diabetic cardiomyopathy","volume":"119","author":"Madonna","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2026.119719_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/457848","article-title":"Low intensity physical exercise attenuates cardiac remodeling and myocardial oxidative stress and dysfunction in diabetic rats","volume":"2015","author":"Gimenes","year":"2015","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.biopha.2026.119719_bib25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1475-2840-12-152","article-title":"Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats","volume":"12","author":"Rosa","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2026.119719_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.140419","article-title":"Effects of acute fluoride exposure on the jejunum and ileum of rats: insights from proteomic and enteric innervation analysis","volume":"741","author":"Dionizio","year":"2020","journal-title":"Sci. Total. Environ."},{"key":"10.1016\/j.biopha.2026.119719_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mce.2008.06.018","article-title":"Proteomics in diabetes research","volume":"297","author":"Sundsten","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2026.119719_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13098-023-01229-0","article-title":"Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes","volume":"15","author":"Liu","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.biopha.2026.119719_bib29","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCULATIONAHA.123.065517","article-title":"Metabolic communication by SGLT2 inhibition","volume":"149","author":"Billing","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2026.119719_bib30","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1113\/JP276747","article-title":"Cardiomyopathy in obesity, insulin resistance and diabetes","volume":"598","author":"Nakamura","year":"2020","journal-title":"J. Physiol."},{"issue":"21-22","key":"10.1016\/j.biopha.2026.119719_bib31","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1007\/s00018-021-03932-5","article-title":"The role of the integral type II transmembrane protein BRI2 in health and disease","volume":"78","author":"Martins","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119719_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.623969","article-title":"Subtle role for adenylate kinase 1 in maintaining normal basal contractile function and metabolism in the murine heart","volume":"12","author":"Zervou","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2026.119719_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115465","article-title":"Identification of glycolytic proteins as binding partners of Bri2 BRICHOS domain","volume":"232","author":"Tigro","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biopha.2026.119719_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2023.103843","article-title":"Identification of cytoskeletal proteins as binding partners of Bri2 BRICHOS domain","volume":"125","author":"Shimozawa","year":"2023","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.biopha.2026.119719_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.791700","article-title":"Proteomic analysis suggests altered mitochondrial metabolic profile associated with diabetic cardiomyopathy","volume":"9","author":"Gomes","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2026.119719_bib36","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10741-022-10271-5","article-title":"Diabetes-induced chronic heart failure is due to defects in calcium transporting and regulatory contractile proteins: cellular and molecular evidence","volume":"28","author":"Rupee","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.biopha.2026.119719_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-023-01755-1","article-title":"The interplay of inflammation, exosomes and Ca2+ dynamics in diabetic cardiomyopathy","volume":"22","author":"Sanganalmath","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2026.119719_bib38","doi-asserted-by":"crossref","first-page":"16139","DOI":"10.3390\/ijms232416139","article-title":"Calcium signalling in heart and vessels: Role of calmodulin and downstream calmodulin-dependent protein kinases","volume":"23","author":"Beghi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119719_bib39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/apha.12766","article-title":"Evidence for a functional role of calsequestrin 2 in mouse atrium","volume":"219","author":"Gergs","year":"2017","journal-title":"Acta Physiol."},{"key":"10.1016\/j.biopha.2026.119719_bib40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4331\/wjbc.v11.i3.76","article-title":"Current understanding of glucose transporter 4 expression and functional mechanisms","volume":"11","author":"Wang","year":"2020","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119719_bib41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.freeradbiomed.2014.12.018","article-title":"IDH2 deficiency promotes mitochondrial dysfunction and cardiac hypertrophy in mice","volume":"80","author":"Ku","year":"2015","journal-title":"Free. Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2026.119719_bib42","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10557-021-07186-y","article-title":"A bioinformatics investigation into the pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in diabetes mellitus and heart failure based on network pharmacology","volume":"36","author":"Mai","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.biopha.2026.119719_bib43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12933-016-0442-1","article-title":"Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus","volume":"15","author":"Rosa","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2026.119719_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2021.03.046","article-title":"Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy","volume":"169","author":"Byrne","year":"2021","journal-title":"Free. Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.biopha.2026.119719_bib45","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3390\/antiox12091675","article-title":"The applications and mechanisms of superoxide dismutase in medicine, food, and cosmetics","volume":"12","author":"Zheng","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2026.119719_bib46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12933-025-02884-5","article-title":"Mitochondrial ultrastructural pathology in diabetic cardiomyopathy: integrated analysis via scanning electron microscopy and 3D visualization imaging","volume":"24","author":"Wang","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2026.119719_bib47","doi-asserted-by":"crossref","first-page":"10146","DOI":"10.3390\/ijms231710146","article-title":"Dapagliflozin mitigates doxorubicin-caused myocardium damage by regulating AKT-mediated oxidative stress, cardiac remodeling, and inflammation","volume":"23","author":"Hsieh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119719_bib48","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/antiox10081166","article-title":"Emergence of SGLT2 inhibitors as powerful antioxidants in human diseases","volume":"10","author":"Tsai","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2026.119719_bib49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4062\/biomolther.2021.192","article-title":"The role of mitochondrial biogenesis dysfunction in diabetic cardiomyopathy","volume":"30","author":"Tao","year":"2022","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.biopha.2026.119719_bib50","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3389\/fphys.2018.01575","article-title":"Direct cardiac actions of sodium glucose cotransporter 2 inhibitors target pathogenic mechanisms underlying heart failure in diabetic patients","volume":"9","author":"Uthman","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2026.119719_bib51","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3389\/fphys.2018.01575","article-title":"Direct cardiac actions of sodium glucose cotransporter 2 inhibitors target pathogenic mechanisms underlying heart failure in diabetic patients","volume":"9","author":"Uthman","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2026.119719_bib52","first-page":"1431","article-title":"The laboratory rat: age and body weight matter","volume":"20","author":"Ghasemi","year":"2021","journal-title":"EXCLI J."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:37:00Z","timestamp":1785875820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226007559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"alternative-id":["S0753332226007559"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119719","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of SGLT2 inhibitor dapagliflozin on the heart of rats with long-standing Type 1 diabetes mellitus: Protein profile","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119719"}}